What's Happening

Stay up to date on pharmaceutical developments, industry issues, and what’s happening with Healthesystems

Events

Healthesystems’ conferences and speaking engagements

National Comp (NWCD Conference)

October 20-21, 2021   Las Vegas, NV

Visit Healthe in booth #830 to participate in our Annual Industry Survey for a chance to win $500.

Attend our VP of Clinical Services, Dr. Silvia Sacalis’ session on Wed 10/20 @ 11:00 Am: “The New Rules of Infectious Disease Post-Pandemic: Adapt, Be Ready, Be Resilient”

WCI Annual Conference

December 12-15, 2021   Orlando, FL

Visit Healthe in the exhibit hall to learn more about our workers’ comp pharmacy & ancillary benefits solutions.

MedMonitor

An up-to-date timeline of FDA approvals that could impact workers' comp
View All MedMonitor Information

Olumiant® (baricitinib)

Approval Date: 2022-05-02

Note: New Product

Indicated for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, and other assistance with breathing

hello world!

Mounjaro (tirzepatide) injection

Approval Date: 2022-05-01

Note: New Product

Indicated for the improvement of glycemic control in patients with type 2 diabetes, in conjunction with diet and exercise

hello world!

Igalmi (dexmedetomidine) sublingual film

Approval Date: 2022-04-04

Note: New Product

Indicated for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder

hello world!

Vimpat (lacosamide) tablets

Approval Date: 2022-03-29

Note: First-Time Generic

A first-time generic for Vimpat, this drug treats partial onset seizures

hello world!

Adlarity (donepezil hydrochloride) transdermal system

Approval Date: 2022-03-22

Note: New Product

Indicated for the treatment of mild-to-severe dementia of the Alzheimer’s type. This product is the first transdermal patch for this indication.

hello world!

Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol

Approval Date: 2022-03-22

Note: First-Time Generic

A first-time generic for Symbicort, this drug is indicated for the treatment of COPD and asthma.

hello world!

Farxiga (dapgliflozin) tablets

Approval Date: 2022-02-28

Note: First-Time Generic

A first-time generic for Farxiga, a medication used to treat type 2 diabetes, as well as adults with certain kinds of heart failure chronic kidney disease.

hello world!

Revex (nalmefene) injection

Approval Date: 2022-02-27

Note: First-Time Generic

A first-time generic of Revex, this drug is indicated for the complete or partial reversal of opioid drug effects, including respiratory depressions from natural or synthetic opioids, and for the management of opioid overdose

hello world!

Aspruzyo Sprinkle (ranolazine) extended release granules

Approval Date: 2022-02-22

Note: New Product

Indicated for the treatment of chronic angina, a type of chest pain caused by reduced blood flow to the heart.

hello world!

Norliqva® (amlodipine) oral solution

Approval Date: 2022-02-21

Note: New Product

A peppermint-flavored solution indicated for the treatment of hypertension and angina. Amlodipine is available as a generic in oral tablets.

hello world!
1 2 3 6

Social Hub

Check out our latest posts and activity
View All Social Media
    lockenvelopephone-handsetmenucross-circle